Lung Cancer 

TL;DR: The results of this meta-analysis suggest that chemotherapy may have a role in treating non-small cell lung cancer, and reached conventional levels of significance when used with radical radiotherapy and with supportive care.

TL;DR: Further validation data on the FACT-G with a subsample of lung cancer patients from the original publication is reported and, more importantly, data is presented on the Lung Cancer Subscale (LCS) which was administered along with the F ACT-G to 116 patients with lung cancer.

TL;DR: This report summarises the epidemiological evidence on the association between tobacco smoking and cancer, which was reviewed by an international group of scientists convened by IARC, and shows a consistent and statistically significant association between exposure to environmental tobacco smoke and lung cancer risk.

TL;DR: The results form international field testing lend support to the EORTC QLQ-LC13 as a clinically valid and useful tool for assessing disease- and treatment-specific symptoms in lung cancer patients participating in clinical trials, when combined with the E ORTC core quality of life questionnaire.

TL;DR: Elevated pre-treatment NLR and PLR are associated with shorter OS and PFS and with lower response rates in patients with metastatic NSCLC treated with nivolumab independently of other prognostic factors.